The Cooper Companies

COO · NASDAQ · USD

57,41 $Variation par rapport à la clôture précédente: +1,56 %Variation absolue: +0,88 $

Clôture · 1 octobre 2026

Profil de la société

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Description disponible en anglais.

Informations sur la société

Secteur
Santé
Industrie
Medical Instruments & Supplies
Siège
6101 Bollinger Canyon Road, 94583, San Ramon
Salariés
15 000
Cotation
COO · NASDAQ
Indices
S&P 500
Devise
USD